Effect of semaglutide in patients with type 2 diabetes and peripheral artery disease: an analysis of the STRIDE trial stratified by disease severity and age
Event:
ESC Congress 2025
Topic:
Peripheral Artery Disease
Session:
Cardiovascular and limb outcomes in peripheral artery disease